Short Wave Short Wave

How a viral video gave a huge boost to new gene therapy

Nov 18, 2026 · 14m

Summary

NPR correspondent Sydney Lubkin revisits the story of the O’Neill family, who raised millions for research into Sanfilippo syndrome after their daughter Eliza was diagnosed. The episode traces the journey from their viral 2014 fundraising campaign to the 2025 FDA approval of Fayuvie, the first gene therapy for the condition. It highlights the decades of scientific effort, the high cost of the treatment, and Eliza’s life as the first patient to receive the experimental therapy.

Topics discussed

Sponsor: Citi Premium Boost Intro: The O'Neill family and Sanfilippo syndrome Sponsors: Betterment, Citi, and Dell Eliza's early signs and diagnosis Understanding Sanfilippo syndrome Haiyan Fu's mouse research and funding The viral 'Saving Eliza' video Clinical trials and FDA approval journey Fayuvie: Availability, age, and pricing Reactions and Eliza's life today Credits and closing Sponsors: Angie and Total Wine

More from Short Wave

This gas station drug acts like opioids. It’s getting harder to buy
Nov 20, 2026
How bird poop and manta rays sustain a pristine coral reef
Nov 17, 2026
Are your body clocks off? Meet ‘circadian depression’
Nov 16, 2026
AI could help hospitals diagnose PTSD in real time
Nov 13, 2026
Can scientists reverse your age?
Nov 11, 2026
Listen ad-free on Castria